Vivo Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer.
BiotechHealthtechMedical DevicesHalifax, CA
Robert Abraham(Co-founder (Interventional Radiologist, MD))inDaniel Boyd(Co-founder (Material Scientist))inSharon Kehoe(Co-founder (Material Scientist))inAnthony Headley(Executive Officer)inGary Donofrio(Executive Officer)inMichael Mangano(Executive Officer, Director)in
Board seatJoseph Siletto· per SEC Form D · $2.6M raise · filed Nov 2025
Co-investorsEight Roads VenturesF-Prime CapitalFirst Angel Network Association (FAN)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







